H-Optimus-0

Bioptimus, an innovative AI-driven biology company, has secured $76 million in funding, including a $41 million Series A round led by Cathay Innovation. This milestone supports the development of a groundbreaking multi-scale, multi-modal foundation model for biology, slated for release…